Edwin Bennett Astwood (December 19, 1909 – February 17, 1976) was a Bermudian-American physiologist and endocrinologist: his research on endocrine system led to treatments for hyperthyroidism, first published in 1943 in what has subsequently been called a "landmark" paper.[1] In 1949 he showed that methimazole was superior to alternative therapies for Graves' disease and this became a standard treatment for the condition.[2]
Edwin Bennett Astwood | |
|---|---|
| Born | December 29, 1909 |
| Died | February 17, 1976 |
| Nationality | Bermudian |
| Awards | Cameron Prize for Therapeutics of the University of Edinburgh (1948) Lasker Award (1954) |
| Scientific career | |
| Fields | Endocrinology |
He was elected a Fellow of the American Academy of Arts and Sciences in 1949.[3] In 1948, he was awarded the Cameron Prize for Therapeutics of the University of Edinburgh. He died of cancer on February 17, 1976, in Hamilton, Bermuda.[4]
References
edit- ^ Astwood, E. B. (1984). "Landmark article May 8, 1943: Treatment of hyperthyroidism with thiourea and thiouracil. By E.B. Astwood". JAMA: The Journal of the American Medical Association. 251 (13): 1743–1746. doi:10.1001/jama.251.13.1743. PMID 6422063.
- ^ Burch, Henry B.; Cooper, David S. (2018). "Antithyroid drug therapy: 70 years later". European Journal of Endocrinology. 179 (5): R261–R274. doi:10.1530/EJE-18-0678. PMID 30320502.
- ^ "Book of Members, 1780-2010: Chapter A" (PDF). American Academy of Arts and Sciences. Retrieved 27 April 2011.
- ^ "Dr. Edwin B. Astwood, 66, a leader in endocrinology". The Boston Globe. February 18, 1976 – via Newspapers.com.
- Cooper, D. Y. Astwood, Edwin Bennett. American National Biography Online Feb. 2000.
External links
edit
   | This biographical article related to a physician in the United States is a stub. You can help Wikipedia by expanding it. |